CRMD
NASDAQ HealthcareCorMedix Inc. - Common Stock
Biotechnology
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
๐ Market Data
| Price | $7.71 |
|---|---|
| Volume | 153,927 |
| Market Cap | 596.66M |
| Beta | 1.500 |
| RSI (14-Day) | 13.1 Oversold |
| 200-Day MA | $8.13 |
| 50-Day MA | $7.92 |
| 52-Week High | $13.02 |
| 52-Week Low | $6.13 |
| P/E Ratio | 3.51 |
| Forward P/E | 21.87 |
| Price / Book | 1.29 |
๐ฏ Investment Strategy Scores
CRMD scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (90/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ Over-Hyped (6/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find CRMD in your text
Paste any article, transcript, or post โ the tool will extract CRMD and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-09-24.